• Kyodo

  • SHARE

Three anti-coronavirus drugs prescribed in Japan, including molnupiravir, may be effective against the omicron subvariant BA.5, according to a study published in the New England Journal of Medicine on Thursday.

A team led by Yoshihiro Kawaoka, a professor of virology at the University of Tokyo, found that small-molecule antiviral drugs nirmatrelvir, molnupiravir and remdesivir curbed virus activity in cultured monkey cells infected with the highly contagious BA.5 and other strains.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)